🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-arm, open-label, multicenter clinical study to evalu...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-07-11
Trial ID
NCT06455254
Treatments Being Tested
This study is a prospective, open-label, dual-arm exploratory Phase II clin...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-06-01
Trial ID
NCT07003022
This study is a single-arm Phase II clinical trial aiming to evaluate the s...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-05-11
Trial ID
NCT06335927
Treatments Being Tested
To evaluate the efficacy and safety of Cadonilimab in combination with Rego...
Status
Unknown
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2023-09-01
Trial ID
NCT05820906
Treatments Being Tested
To evaluate the efficacy and safety of cadonilimab combined with Regorafeni...
Status
Recruiting
Location
Mengchao Hepatobiliary Hospital, Fujian Medical University
Start Date
2024-03-31
Trial ID
NCT06280105
Treatments Being Tested
To evaluate the efficacy and safety of Cadonilimab Injection in combination...
Status
Unknown
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2022-11-25
Trial ID
NCT05644392
Treatments Being Tested
To evaluate the efficacy and safety of Cadonilimab Injection in combination...
Status
Active Not Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2022-11-24
Trial ID
NCT05644379
Treatments Being Tested
To evaluate the efficacy and safety of cadonilimab combined with regorafeni...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2023-09-19
Trial ID
NCT05773105
Treatments Being Tested